Doctor profile · Federal record
Dr. DANIEL HANSEN, D.P.M.
Foot & Ankle Surgery Podiatrist (CMS: PODIATRY) · Student in an Organized Health Care Education/Training Program · SALT LAKE CITY, UT
- NPI 1316325590
- Accepts Medicare
- 11 yrs in practice
- Licensed in 2 states
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
660 S 200 E STE 250
SALT LAKE CITY, UT 841113846
(801) 359-2256
fax (801) 364-4392 - Mailing address
-
1141 W LOVERS CV
RIVERTON, UT 840656110
Credentials & registration
- NPI registered
- May 2015 — 11 yrs on file
- Profile last updated
- May 21, 2025
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 213ES0103X — NUCC code
- State licenses (2)
- Utah #10722129-0501 · Massachusetts #1340
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1316325590. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,146
Distinct HCPCS
10
Medicare allowed
$76,049
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 279 | 117 | $85 | |
11721 |
Removal of fingernails or toenails, 6 or more nails | 200 | 72 | $42 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 140 | 79 | $122 | |
73630 |
X-ray of foot, minimum of 3 views | 114 | 62 | $32 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 77 | 22 | $0 | |
11056 |
Removal of noncancer thickened skin growth, 2-4 growths | 52 | 25 | $75 | |
11055 |
Removal of noncancer thickened skin growth, 1 growth | 42 | 27 | $64 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 39 | 39 | $103 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 39 | 14 | $1 | |
11057 |
Removal of noncancer thickened skin growth, more than 4 growths | 31 | 12 | $85 |
In context: peer comparison
Among 8 peers in this city , average services per provider: 77. This provider delivers 15× the peer median.Open Payments
Industry payments received
All-time total
$623
Transactions
28
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen Inc. | 9 | $210.81 | |
| Stryker Corporation | 3 | $90.19 | |
| Bioventus LLC | 3 | $47.24 | |
| Orthofix Medical, Inc. | 1 | $41.34 | |
| Integra LifeSciences Corporation | 2 | $40.20 | |
| TRICE MEDICAL, INC. | 1 | $33.68 | |
| TREACE MEDICAL CONCEPTS, INC. | 2 | $33.58 | |
| Paratek Pharmaceuticals, Inc. | 2 | $30.66 | |
| Solventum Corporation | 1 | $21.41 | |
| Innovation Technologies Inc | 1 | $20.99 | |
| MIMEDX Group, Inc. | 1 | $19.22 | |
| Averitas Pharma Inc. | 1 | $17.66 | |
| BIOCOMPOSITES INC | 1 | $16.04 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
78
Patients
26
Total drug cost
$874
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Cephalexin | Generic | 30 | 26 | $229 |
| Doxycycline Hyclate | Generic | 19 | 0 | $443 |
| Oxycodone Hcl | Generic | 17 | 0 | $79 |
| Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) | Brand | 12 | 0 | $123 |